Dr. Parkash is a professor of medicine at Dalhousie University, from 2004 until the present. She has two major areas of research: atrial fibrillation (AF) and cardiac implantable electronic devices (CIEDs). Dr. Parkash is involved in a number of clinical trial initiatives in atrial fibrillation focused on mechanisms of disease and management strategies. She continues to investigate prevention of recurrent atrial fibrillation in patients with heart failure or a high symptom burden to prevent future cardiovascular events and improve quality of life. In the area of CIEDs, the main research areas include device recalls, management, outcomes, complications, heart failure, virtual care strategies, as well as prevention of sudden death. Dr. Parkash is the past Chair of the Canadian Heart Rhythm Society Device Committee and is the Associate Scientific Director of the Cardiovascular Network, and has been awarded the title of Distinguised Research Professor in 2020 at Dalhousie University.